Enliven Therapeutics shares owned by Letko, Brosseau & Associates
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Letko, Brosseau & Associates
from 13F filings
Historical chart of Letko, Brosseau & Associates investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Letko, Brosseau & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Letko, Brosseau & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $376k | 9.6k | 39.20 |
More positions owned by Letko, Brosseau & Associates
View all positions for Letko, Brosseau & Associates